34 Recruiting Studies Using Folfiri
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Folfiri
CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab
📍 The University of Kansas Cancer Center (KUCC) — Fairway, Kansas
Colon Cancer
View Study & Checklist ➔Saltikva for Metastatic Pancreatic Cancer
📍 Segal Cancer Centre/ Mortimer B. Davis-Jewish General Hosptial — Montreal, Quebec
Metastatic Pancreatic Cancer
View Study & Checklist ➔Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
📍 Local Institution - 010-855-E — Alabaster, Alabama
Advanced Colorectal Cancer
View Study & Checklist ➔Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
📍 Mayo Clinic - Arizona — Phoenix, Arizona
Metastatic Colorectal Cancer
View Study & Checklist ➔Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma
📍 University of Arizona — Tucson, Arizona
Pancreas Cancer
View Study & Checklist ➔Redefining FOLFIORINOX in Older Pancreatic Cancer Patients
📍 Fox Chase Cancer Center — Philadelphia, Pennsylvania
Metastatic Pancreatic Cancer
View Study & Checklist ➔Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
Metastatic Colorectal Cancer
View Study & Checklist ➔Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
📍 University of Colorado Cancer Center — Aurora, Colorado
Pancreatic Cancer
View Study & Checklist ➔A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
📍 University of Alabama — Birmingham, Alabama
Colon Cancer
View Study & Checklist ➔ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
📍 MD Anderson Cancer Center — Houston, Texas
Dynamic Tumor Resistance
View Study & Checklist ➔Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
📍 Baylor College of Medicine — Houston, Texas
Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
📍 Arizona Oncology Associates — Tucson, Arizona
Cancer
View Study & Checklist ➔Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
📍 Vista Oncology — Olympia, Washington
Left-sided Colorectal Cancer
View Study & Checklist ➔Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
📍 Ironwood Cancer and Research Centers Scottsdale — Chandler, Arizona
Metastatic Colorectal Cancer
View Study & Checklist ➔A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
📍 University of Arizona Cancer Center — Tucson, Arizona
Colorectal Neoplasms
View Study & Checklist ➔A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
📍 The Angeles Clinic and Research Institute — Los Angeles, California
Solid Tumors
View Study & Checklist ➔Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)
📍 Chao Family Comprehensive Cancer Center, University — Orange, California
Gastroesophageal Adenocarcinoma
View Study & Checklist ➔Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
📍 City of Hope (City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California
Gastric or Gastroesophageal Junction Adenocarcinoma
View Study & Checklist ➔alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
📍 Moffit Cancer Center — Tampa, Florida
Unresectable Metastatic Colorectal Cancer
View Study & Checklist ➔Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
Pancreatic Adenocarcinoma Metastatic
View Study & Checklist ➔A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
📍 Research Site — Scottsdale, Arizona
Metastatic Colorectal Cancer
View Study & Checklist ➔Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
📍 Icahn School of Medicine at Mount Sinai — New York, New York
Pancreatic Cancer
View Study & Checklist ➔Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
📍 Precision NextGen Oncology — Beverly Hills, California
Diffuse Astrocytoma, IDH-Mutant
View Study & Checklist ➔FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
📍 Central Alabama Research — Homewood, Alabama
Ras-mutated Metastatic Colorectal Cancer
View Study & Checklist ➔A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
📍 Mayo Clinic Hospital — Phoenix, Arizona
Solid Tumors
View Study & Checklist ➔Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
📍 University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
Pancreatic Adenocarcinoma
View Study & Checklist ➔A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
📍 Local Institution - 0428 — Tucson, Arizona
Untreated, Unresectable, or Metastatic Colorectal Cancer
View Study & Checklist ➔Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
📍 Massachusetts General Hospital — Boston, Massachusetts
Metastatic Colon Cancer
View Study & Checklist ➔Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
📍 University of Louisville — Louisville, Kentucky
Pancreas Cancer
View Study & Checklist ➔A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
📍 Rocky Mountain Cancer Center - Primary — Denver, Colorado
Colon Cancer
View Study & Checklist ➔A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
📍 UAB Comprehensive Cancer Center — Birmingham, Alabama
Metastatic Colorectal Cancer
View Study & Checklist ➔Trial of ProAgio in Advanced/Metastatic Colorectal Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
Advanced Colorectal Cancer
View Study & Checklist ➔A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
📍 Next Oncology-Austin — Austin, Texas
Locally Advanced Unresectable or Metastatic Solid Tumors
View Study & Checklist ➔Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
📍 Banner Health- MD Anderson Cancer Center — Gilbert, Arizona
Non-small Cell Lung Cancer
View Study & Checklist ➔